Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

DKSH (CAMBODIA) LIMITED

UEI: SLED_8DD691FE88A63C2F

DKSH (CAMBODIA) LIMITED is a federal contractor, registered under UEI SLED_8DD691FE88A63C2F. It has been awarded $66,220 across 1 federal contract. Primary work spans Medical Laboratories. Top awarding agencies include US Embassy Phnom Penh.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_8DD691FE88A63C2F

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
US Embassy Phnom Penh$66.2K100%
Awards by NAICS
621511 - Medical Laboratories$66.2K100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in DKSH (CAMBODIA) LIMITED's top NAICS codes and agencies

NAICS: 621511
New
Federal
Q301--Q&A CYTOPATHOLOGY AND NEXT GENERATION SEQUENCING TESTING SERVICES CLOSE 08/21/2026 17:00
Solicitation # 36C24226Q0875
Solicitation 36C24226Q0875 is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract issued by the Department of Veterans Affairs for the Northport VA Medical Center. The objective is to secure comprehensive, clinically validated molecular diagnostic testing using Next Generation Sequencing (NGS) to improve the management of thyroid nodules with indeterminate fine-needle aspiration (FNA) cytology. The contract covers a five-year performance period from October 1, 2026, to September 30, 2031, with a minimum quantity of 30 tests and a maximum of 600 tests. The scope includes cytopathology evaluation, reflex molecular testing, the provision of collection and shipping kits, and professional consultation. Award will be based on best-value, where technical capability and past performance are weighted more heavily than price. Key evaluation factors include diagnostic performance, molecular testing capabilities, quality management certifications such as CLIA and CAP, and the qualifications of key personnel, specifically board-certified molecular pathology oversight. While the solicitation is not set aside for small businesses, evaluation credit will be granted to Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB) verified in the VIP database. Quotes must be submitted electronically to Contract Specialist Mariangie Rivera by 5:00 PM EST on August 21, 2026.
242-NETWORK Contract Office 02 (36C242)

POSTED

3 days ago

DEADLINE

in 5 days
View Details